
Ginny Mason/LinkedIn
Aug 30, 2025, 17:51
Ginny Mason: The Importance of Monitoring Blood Clot Risks in Cancer Patients
Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:
“Cancer Patients are at greater risk for blood clots, yet many patients aren’t aware of this increased risk. It’s especially important that Clinical Trials monitor and report accurate results.”
More posts featuring Ginny Mason on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 30, 2025, 17:51
Aug 30, 2025, 17:43
Aug 30, 2025, 17:35
Aug 30, 2025, 16:37
Aug 30, 2025, 15:59
Aug 30, 2025, 15:39